This inventor holds 1 USPTO granted patent. Top assignee: Cancer Research Technology Limited. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Anthony Reskza: Innovator in Therapeutic Compounds
Introduction
Anthony Reskza is a notable inventor based in London, GB. He has made significant contributions to the field of therapeutic compounds, particularly in the development of acridone and acridine compounds. His work focuses on innovative solutions for treating proliferative conditions, including cancer.
Latest Patents
Anthony Reskza holds a patent for "Therapeutic acridone and acridine compounds." This invention pertains to specific acridone and acridine compounds that have potential applications in inhibiting telomerase and regulating cell proliferation. The patent outlines various chemical structures and their pharmaceutical compositions, which can be utilized both in vitro and in vivo for therapeutic purposes.
Career Highlights
Reskza is associated with Cancer Research Technology Limited, where he applies his expertise in medicinal chemistry. His work is pivotal in advancing research aimed at developing effective treatments for cancer and other proliferative diseases.
Collaborations
He has collaborated with esteemed colleagues such as Stephen Neidle and Richard John Harrison, contributing to the collective effort in cancer research and therapeutic development.
Conclusion
Anthony Reskza's innovative work in therapeutic acridone and acridine compounds showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer and other proliferative conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile